SENSIPHI
Live / Registered — Registered — international registration renewed (as of 30 Jun 2025)
What this means for you
Registered since 07 Apr 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79146712
- Registration number
- 4714429
- Mark type
- Stylized text
- Filed
- 13 Jan 2014
- Published for opposition
- 20 Jan 2015
- Registered
- 07 Apr 2015
- Attorney of record
- Daniel M. Gurfinkel
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular chemical reagents, enzymes and chemical solutions in the nature of buffer solutions for nucleic acid amplification; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification; kits containing preparations for medical and veterinary diagnostic purposes, primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplifying, sequencing and/or for the analysis of bio polymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid amplification
Owner
- Qiagen GmbH, Hilden, DE
- Qiagen GmbH, 40724 Hilden, DE
- Qiagen GmbH, 40724 Hilden, DE
Prior registrations
Prosecution history
- 30 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 30 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 30 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
- 07 Apr 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 04 Jan 2024 — INTERNATIONAL REGISTRATION RENEWED
- 16 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 16 Jun 2021 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 16 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2021 — TEAS SECTION 71 & 15 RECEIVED
- 07 Apr 2020 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 18 Oct 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Sept 2015 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Aug 2015 — FINAL DISPOSITION NOTICE SENT TO IB
- 14 Aug 2015 — FINAL DISPOSITION PROCESSED